blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1303258

EP1303258 - NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.08.2007
Database last updated on 03.09.2024
Most recent event   Tooltip21.12.2007Change - lapse in a contracting state
State(s) deleted from list of lapses: IT
published on 23.01.2008  [2008/04]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2003/17]
Inventor(s)01 / ROGUEDA, Philippe, AstraZeneca R&D Charnwood
Bakewell Road
Loughborough LE11 5RH / GB
 [2003/17]
Application number, filing date01952071.710.07.2001
[2003/17]
WO2001SE01606
Priority number, dateGB2000001687611.07.2000         Original published format: GB 0016876
[2003/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0203958
Date:17.01.2002
Language:EN
[2002/03]
Type: A1 Application with search report 
No.:EP1303258
Date:23.04.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 17.01.2002 takes the place of the publication of the European patent application.
[2003/17]
Type: B1 Patent specification 
No.:EP1303258
Date:11.10.2006
Language:EN
[2006/41]
Search report(s)International search report - published on:SE17.01.2002
ClassificationIPC:A61K9/12, A61K9/72, A61K47/24
[2003/17]
CPC:
A61K9/008 (EP,US); A61K9/12 (KR); A61K47/24 (EP,US);
A61P11/02 (EP); A61P11/06 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/17]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SI11.02.2003
TitleGerman:NEUE AEROSOLFORMULIERUNGEN EIN POLARES FLUORINIERTES MOLEKÜL ENTHALTEND[2003/17]
English:NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE[2003/17]
French:NOUVELLE PREPARATION EN AEROSOL CONTENANT UNE MOLECULE FLUOREE POLAIRE[2003/17]
Entry into regional phase11.02.2003National basic fee paid 
11.02.2003Designation fee(s) paid 
11.02.2003Examination fee paid 
Examination procedure22.01.2002Request for preliminary examination filed
International Preliminary Examining Authority: SE
11.02.2003Examination requested  [2003/17]
19.10.2005Despatch of a communication from the examining division (Time limit: M04)
10.11.2005Reply to a communication from the examining division
20.03.2006Communication of intention to grant the patent
31.07.2006Fee for grant paid
31.07.2006Fee for publishing/printing paid
Opposition(s)12.07.2007No opposition filed within time limit [2007/38]
Fees paidRenewal fee
31.07.2003Renewal fee patent year 03
02.08.2004Renewal fee patent year 04
01.08.2005Renewal fee patent year 05
31.07.2006Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2008/04]
Former [2007/36]IT11.10.2006
Cited inInternational search[A]US3557294  (DEAR ROBERT E A, et al);
 [X]WO9111173  (FISONS PLC [GB]);
 [X]US5849265  (LI-BOVET LI [US], et al);
 [XP]US6149892  (BRITTO IGNATIUS LOY [US]);
 [A]  - EDMOND I. EGER II ET AL., "Minimum alveolar anesthetic concentration of fluorinated alkanols in rats: Relevance to theories of narcosis", ANESTH. ANALG., (1999), vol. 88, pages 867 - 876, XP002948159

DOI:   http://dx.doi.org/10.1097/00000539-199904000-00035
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.